ImmunityBio
IBRXHealthcare · Biotechnology · US6.02USDImmunityBio, Inc., a biotechnology company, develops and commercializes immunotherapies designed to activate the patient's immune system against cancer and infectious diseases.
1D−8.4%1W0.0%1M−30.3%
Loading chart…
Checks
- Locked: Price trend
- Locked: Sales growth against its peers
- Locked: Profit against similar companies
- Locked: What analysts expect
- Locked: Price against what it earns
- Locked: Last quarter against forecasts
See how ImmunityBio does on each check. Sign in for two weeks free, with no card. Then StratDeck Pro is £5.99 a month or £60 a year.
Sign in